The global CNS disorders market, in 2022, was valued at $116 billion, ranking it as the fourth largest therapy area behi...
Dr Samantha SHAN, Research Assistant Professor of the School of Optometry of The Hong Kong Polytechnic University (PolyU...
Triastek Inc., a global leader in 3D printing pharmaceuticals, has entered into a research collaboration and platform te...
Scientists at the University of Sydney, Australia and Liverpool School of Tropical Medicine, UK have made a remarkable d...
GC Cell Corporation and Taiwan-based Lukas Biomedical has formally signed an international strategic cooperation agreeme...
A team of scientists led by Associate Professor Ashley St John from Duke-NUS’ Emerging Infectious D...
Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient'...
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among ...
TMS Co. has entered into an exclusive worldwide license agreement with Hokkaido University concerning a therapeuti...
Union Minister for Science and Technology, Government of India, Dr Jitendra Singh has unveiled the results of the 15th r...
A University of Sydney team have successfully created a transparent microchip with the potential to reduce the testing o...
A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s G...
Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. The Chinese...
A new biotech company launched on 18th June in Australia will use a world-leading technology to target cancers that are ...
To increase patient access to affordable, advanced genomic testing for cancer in Singapore, Thermo Fisher Scientific Inc...
Having previously pivoted towards medical devices more than 10 years ago, Singapore has recently seen a biotech resurgen...
Researchers at University of Auckland in New Zealand are working on an innovative way to treat an aggressive blood cance...
While in Geneva to advance Australia’s interests at the World Health Organization’s (WHO) World Health Assem...